• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100139
Device Problems Improper or Incorrect Procedure or Method (2017); Incorrect Or Inadequate Test Results (2456); Low Test Results (2458)
Patient Problems Abdominal Pain (1685); Coagulation Disorder (1779); Toxicity (2333)
Event Date 09/10/2015
Event Type  Injury  
Manufacturer Narrative
Investigation is pending.
 
Event Description
The customer alleged a variance between the inratio inr result and the laboratory inr result.On (b)(6) 2015 at 8:54 am, a patient was tested on the facility's inratio monitor and the inr result was 2.0.Reportedly, multiple drops of blood was applied to the inratio testing strip.This is considered to be an improper technique when performing the inratio test.At 5:00 pm, the patient was hospitalized for coumadin toxicity (laboratory inr=7.2) and abdominal pain (kidney cyst hemorrhage).Treatment included discontinuation of coumadin, normal saline bolus, zofran 4mg iv, morphine 5mg iv, vitamin k 10mg, k-dur 40 meq orally and a normal saline with potassium infusion.The patient recovered and was discharged from the hospital on (b)(6) 2015.There was no additional information provided.
 
Manufacturer Narrative
Investigation/conclusion: the meter and strips associated with the complaint were returned for investigation.The customer's complaint was not confirmed during in-house testing.Returned and retain strips tested on the returned meter met accuracy criteria.When reviewing in-house testing for lot 369159a, no product deficiency was found.A review of the manufacturing records for lot 369159a did not uncover any non-conformances.The lot meets release specification.The returned meter passed functional and thermistor testing during in-house investigation.Although an improper technique was identified in the complaint, root cause is unable to be determined from the information provided.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9975 summers ridge road
san diego CA 92121
Manufacturer (Section G)
ALERE SAN DIEGO, INC.
9975 summers ridge road
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge road
san diego, CA 92121
8588052084
MDR Report Key5131122
MDR Text Key27673951
Report Number2027969-2015-00829
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Followup
Report Date 09/18/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number100139
Device Lot Number369159A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/29/2015
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/07/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received11/12/2015
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
IBUPROFEN 800MG EVERY 8 HOURS ORALLY
Patient Outcome(s) Hospitalization; Required Intervention;
-
-